The Wnt/β-catenin signaling cascade also contributed to enhanced resistance to various chemotherapeutic agents in CRC through upregulating MDR1 as reviewed by Yuan et al. [142]. This evidence concerns the gene ABCB1 and colorectal carcinoma.